Embla Medical hf. (OTCMKTS:OSSFF – Get Free Report) is expected to be posting its resultson Tuesday, July 21st. Analysts expect Embla Medical hf. to announce earnings of $0.0555 per share and revenue of $255.76 million for the quarter.
Embla Medical hf. Price Performance
Shares of OTCMKTS:OSSFF opened at $4.15 on Tuesday. The company’s fifty day moving average is $4.15 and its two-hundred day moving average is $4.54. Embla Medical hf. has a 12-month low of $4.15 and a 12-month high of $5.33.
Embla Medical hf. Company Profile
Embla Medical hf., headquartered in Reykjavik, Iceland, develops and manufactures diagnostic medical devices for sleep, respiratory and neurophysiological monitoring. The company is publicly listed on Nasdaq Iceland and trades in the United States on the OTC market under the symbol OSSFF.
Embla Medical’s engineering and R&D teams design comprehensive solutions that combine hardware, sensors, electrodes and analysis software. Its portfolio includes ambulatory sleep assessment systems suitable for both in-lab and home-based polysomnography, as well as open-platform devices capable of capturing bioelectrical signals such as EEG, ECG and respiratory effort.
Beyond sleep diagnostics, the company’s technology supports respiratory care monitoring and neurophysiology research.
See Also
- Five stocks we like better than Embla Medical hf.
- The SK Hynix IPO and 2027’s AI Memory Squeeze
- Meta Platforms Stock Rises as Muse Spark 1.1 AI Model Debuts
- Why Welltower’s Growth Story Might Outrun Its Rich Valuation
- One Short- and One Long-Term ETF for Quantum Computing Bulls
Receive News & Ratings for Embla Medical hf. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Embla Medical hf. and related companies with MarketBeat.com's FREE daily email newsletter.
